AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Personality Profile of Patients With Apical Ballooning Syndrome

Completed

Conditions: Apical Ballooning Syndrome

First Posted Date: 2013-06-25

Last Posted Date: 2015-02-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 53

Registration Number: NCT01885975

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Application for Self-Monitoring of Cardiovascular Risk

Not Applicable

Completed

Conditions: Coronary Disease

Interventions: Device: Self Monitoring Software Application

First Posted Date: 2013-06-21

Last Posted Date: 2018-03-23

Lead Sponsor: Mayo Clinic

Target Recruit Count: 80

Registration Number: NCT01883050

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream

Phase 1

Completed

Conditions: Pain

Interventions: Drug: Capsaicin 0.1%
Drug: Placebo

First Posted Date: 2013-06-21

Last Posted Date: 2013-06-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01883102

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Cryotherapy -BEATS-RF Ablation Trial

Completed

Conditions: Barrett's Esophagus With Persistent Dysplasia or
Early Esophageal Adenocarcinoma Post Radio Frequency Ablation

First Posted Date: 2013-06-20

Last Posted Date: 2021-10-20

Lead Sponsor: Mayo Clinic

Target Recruit Count: 15

Registration Number: NCT01882478

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer

Phase 2

Completed

Conditions: Non-small Cell Lung Cancer
Small Cell Lung Cancer
Dyspnea

Interventions: Drug: placebo
Drug: lisinopril

First Posted Date: 2013-06-19

Last Posted Date: 2020-01-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 23

Registration Number: NCT01880528

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy

Not Applicable

Completed

Conditions: Laryngopharyngeal Reflux
Zenker's Diverticulum

Interventions: Procedure: Cricopharyngeal myotomy
Diagnostic Test: PH probe Testing

First Posted Date: 2013-06-19

Last Posted Date: 2022-07-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 10

Registration Number: NCT01880892

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

A Program of Physician Supervision to Improve the Quality of Patient Referrals From Nurse Practitioners and Physician Assistants

Not Applicable

Terminated

Conditions: Complex Patients

Interventions: Behavioral: versus NPs and PAs who are not required to discuss patient referrals (control group).
Behavioral: Consultations between NPs and PAs and their supervising physicians

First Posted Date: 2013-06-11

Last Posted Date: 2019-10-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 42

Registration Number: NCT01875068

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Feasibility Study of IV Recombinant Tissue Plasminogen Activator (rtPA) vs. Primary Endovascular Therapy for Acute Ischemic Stroke

Phase 2

Terminated

Conditions: Ischemic Stroke
Stroke

Interventions: Device: Endovascular Arterial Reperfusion
Drug: Intravenous Thrombolysis

First Posted Date: 2013-06-05

Last Posted Date: 2016-10-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01869478

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery

Phase 2

Completed

Conditions: Female Reproductive Cancer

Interventions: Other: placebo
Biological: serum-derived bovine immunoglobulin protein isolate
Other: laboratory biomarker analysis
Other: quality-of-life assessment
Other: questionnaire administration